Question

What commercialization obstacles has the company Medalogix faced, and what should it gear its market segments in the future?

Answer 1

"Healthcare is behind the curve as it relates to data science, even as the biggest tech organizations are putting billions of dollars in machine learning. Google, Amazon, Microsoft and IBM are driving the charge while the overall spend for Artificial Intelligence is anticipated to develop to almost $20 billion of every 2018 alone, which speaks to a 54% expansion over the earlier year," said Elliott Wood, president and CEO of Medalogix. "Machine learning innovation enables us to help out patients that require extra clinical consideration. That is the thing that drives our organization – we endeavor to help other people accomplish more with less. Extraordinary innovation alone won't get us there, but great technology in the hands of great clinicians will be a giant step forward."

Medalogix Care analyzes each patient's clinical and functional assessment and provides an objective determination of how many home health visits a patient may need to achieve the desired outcome.

Medalogix's data scientists identified several trends that were surprising. For example, based on analysis of multiple patient populations, Medalogix found a clear trend of diminishing returns and reduced visit effectiveness for some patients earlier in the home health episode of care than what was expected. With the industry average number of visits provided per episode ranging between 15 and 19 visits per episode, this will create resource capacity for an agency's higher risk patient population. Early simulations of the data suggest that a home health agency should be able to reduce visits by a significant amount while achieving the same or better outcomes. With the ability to optimize episodes and resources, patients with high-risk needs are likely to get more care than what they've experienced historically.

The experimental run program of Medalogix Care started in October 2017 with long-term client Encompass Health. "We invest a considerable measure of energy and assets guaranteeing the information we gather is precise. Our nursing and recovery experts are amazing at thinking about patients in the home setting, however constructing a 'without flaw' care plan is exceptionally troublesome on the grounds that there are truly many components to consider for every patient," said Bud Langham, boss clinical officer at Encompass Health-Home Health and Hospice. "Having proof based proposals and factual help to enlarge our clinical basic leadership is basic as we keep on advancing toward an esteem based framework. As an industry, we need to arrive to guarantee our patients get the correct consideration, by the correct orders, at the opportune time."

Early feedback from the clinical users piloting the technology have said the evidence-based recommendations provide an objective resource for evaluating patient-specific visit needs, augmenting the field staff recommendations and experience.

Furthermore, customers can leverage this technology to approach commercial plans and enter into value-based arrangements. "Having these kinds of capabilities has the potential to change the conversation with our strategic partners," said Luke James, chief strategy officer at Encompass Health-Home Health and Hospice. "We've been able to partner with Medalogix in the past to identify risks within our patient populations, and this allows us to take risk in a measured fashion and have confidence in our approach."

The need for technologies like this is growing, especially in light of the recently initiated CMS Home Health Groupings Model, which will fundamentally change how agencies are reimbursed. The Medalogix platform is currently integrated with several home health and hospice electronic medical records (EMRs) and is the only portfolio of predictive analytics products focused on improving patient outcomes in the home health space.

About Encompass Health

As a national pioneer in post-intense consideration, Encompass Health (NYSE: EHC) offers both office based and locally established patient consideration through its system of inpatient restoration doctor's facilities, home wellbeing organizations and hospice offices. With a national impression that traverses 127 clinics and 268 home wellbeing and hospice areas in 36 states and Puerto Rico, the Company is focused on conveying great, financially savvy care over the post-intense continuum. Driven by an arrangement of shared qualities, Encompass Health is the aftereffect of the relationship between HealthSouth Corporation and Encompass Home Health and Hospice, and is ranked as one of Fortune's 100 Best Companies to Work For, as well as Modern Healthcare's Best Places

About Medalogix:

Medalogix was founded in 2012 with the desire to help home health agencies identify patients on census at-risk for unplanned rehospitalization. Since that time, Medalogix has developed products and services that help home health providers create clinical programs, manage large populations more efficiently, and drive value to strategic partnerships.

Medalogix products have been recognized by Harvard Business Review, HIMSS, Fierce Healthcare, and Becker's Hospital Review as innovative solutions for improving America's healthcare system.

.